Otterbein University

Digital Commons @ Otterbein
Nursing Student Class Projects (Formerly MSN)

Student Research & Creative Work

Summer 7-30-2018

Pathophysiology of Infective Endocarditis (IE) Associated with
Intravenous Drug Use
Kaleigh Cline
Otterbein University, cline@otterbein.edu

Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn
Part of the Cardiovascular Diseases Commons, and the Nursing Commons

Recommended Citation
Cline, Kaleigh, "Pathophysiology of Infective Endocarditis (IE) Associated with Intravenous Drug Use"
(2018). Nursing Student Class Projects (Formerly MSN). 286.
https://digitalcommons.otterbein.edu/stu_msn/286

This Project is brought to you for free and open access by the Student Research & Creative Work at Digital
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an
authorized administrator of Digital Commons @ Otterbein. For more information, please contact
digitalcommons07@otterbein.edu.

Pathophysiology of Infective Endocarditis (IE) Associated with Intravenous Drug Use
Kaleigh Cline BSN, RN
Otterbein University, Westerville, Ohio
Underlying Pathophysiology

Introduction

Underlying Lesion: Degenerative processes such as fibrosis, calcification, congenital heart diseases, mechanical
lesions secondary to material implantation, and turbulent blood flows (IVDU) causes endocardial
damage. This then exposes the extracellular matrix and results in apoptosis of endocardial cells which
then produces tissue factor and a non-bacterial thrombus formation. This thrombotic formation is
known as a “vegetation.” (Thuny, 2016, p.1)

•Intravenous drug use (IVDU) poses many risks to those who use them. One of
the risks being infective endocarditis.
•“Infective endocarditis (IE) is an infectious microbial disease of the heart
valvular endothelium.

Upper panel: Infective
endocarditis producing
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increased aggregation and
proinflammatory cytokine
production with propagation of
vegetation.

• The characteristic lesion consists of the presence of vegetations that can settle
in the valvular veils, tendon cords or mural endocardium” (Molinos, 2018, p.
1).
•Complications of IE include: congestive heart failure, embolization of septic
emboli to other organs, periannular extension of infection, metastatic foci of
infection, mycotic aneurysms, and anticoagulation issues (Baddour, et. al.,
2015, pp. 32-37).

Lower panel: Organism
possessing decreased adhesion
capacity, leading to lower levels
of inflammation and no
endocarditis.

• Contemporary multicentre assessments of outcomes in IE have estimated
inpatient mortality between 14% and 18% (Tung et. al, 2015, p.412).

Signs & Symptoms

Image retrieved from: Keynan,
Y., & Rubinstein, E. (2013)

Most Common
• High fever (usually above 100.4˚F)
• Chills
• Night sweats
• Headaches
• Shortness of breath
• Cough
• Cardiac murmmurs
• Fatigue
• Muscle and joint pain

Host-Pathogen Interaction: Pathogens adhere to the exposed extracellular matrix proteins, referred to as Microbial
Surface Component Reacting with Adhesive Matric Molecules, released by the non-bacteral thrombotic vegetation.
After the pathogen adheres to the vegetation, colonization and invasion of the myocardium occurs and maintains the
inflammatory and coagulation processes. The vegetation will continue to grow (neoangiogenesis) and distroy the
valve tissue. (Thuny, 2016. p. 1-2)

Other Symptoms

A destructive lesion
(arrow) of the mitral
valve of the heart and b
viewed from its
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Significance of Pathophysiology

• Heart Failure - Heart failure is the most common complication from IE and can often leads to surgical
intervention (Habib, et. al, 2015, p. 26). Myocardial tissue death from a bacterial vegetation causes
valvular insufficiency and regurgitation, leading to heart failure.
• Uncontrolled Infection – IE can lead to a persisting infection (positive blood cultures for greater than 710 days) and a perivalvular extension of the original infection. Some pathogens in IE can be resistant to
antibiotics and be even more difficult to treat. According to Habib, et. al., (2015), “Perivalvular extension
of IE is the most frequent cause of uncontrolled infection and is associated with a poor prognosis and
high likelihood of the need for surgery” (p. 26).
• Embolism – Embolic events are very frequent (up to 25% have already occurred upon diagnosis of IE)
and can be fatal. Splenic and brain emboli are the most common site with left-sided IE. Pulmonary
embolism and pacer lead embolism are the most common type with right-sided IE. The risk of embolism
falls from 20-50% to 6-12% after IV antibiotic initiation (Habib et, al., 2015, p. 28). Therefore, early
diagnosis and initiation of IV antibiotics in IE is imperative.

•
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According to Lapkus and Prahlow (2015), “the risk of IE in IVDU is estimated at 2%-5% per year (p. 610)
•

“Staphylococcus aureus accounts for more than one-half of cases of IE among IVDUs. Streptococci and
enterococci are the next most common pathogens. Less commonly, fungi and gram-negative bacilli can also
cause IE in IDUs” (UpToDate, 2018).

Infective Endocarditis is a
serious condition associated that
if not treated, can lead to death.

•

IE has an affect on many other
vital body systems.

•

IVDU puts the patient at risk for
developing IE.

•

Key pathophysiology points:
•
Damage to
myocardial tissue
makes tissue prone
to bacterial
attachment.
•
IVDU allows an
easy route for
bacteria to enter
the bloodstream
and attach to the
valve (vegetation.)
•
Vegetation growth
damages the valves
to dysfunction and
can lead to other
organ damage (as
earlier discussed.)

•

Nurses must monitor patients
with IE closely for complications.

•

Educating patients with IE on
IVDU cessation is important to
prevent reoccurrence.

• Splenic complications – When a piece of the vegetation embolizes and lodges in the spleen and infarct
occurs and is often asymptomatic. Although not as common, splenic abscesses also may occur and
require surgical treatment.
• Cardiac Disturbances – Myocarditis and pericarditis may occur from abscess formation from IE. This
may lead to ventricular arrhythmias that often prove fatal. Pericardial effusions and aneurysms
involving the pericardium may also occur. Conduction abnormalities such as heart blocks and atrial
fibrillation may occur due to the spread of infection beyond the endocardium, through the valves and
into conduction pathways. Myocardial ischemia or myocardial infarction may also occur if an embolus
travels to the coronary arteries.
• Renal Failure – Acute renal dysfunction (ARD) occurs in about 6-30% of IE patients and may worsen
the prognosis of IE as ARD is independently associated with increased hospital mortality (Habib et. al.,
2015, p. 30) This complication of IE may change the dosage of IV antibiotics to allow for renal
considerations.

Implications for Nursing Care
• Assess patients for signs and symptoms of IE and report findings timely to the physician.
•Obtain a thorough health history, specifically regarding cardiac and IVDU history.

In the instance of IVDU, the pathogen is introduced into the host via bacteria located on the skin, the needle, or
the substance being injected. The key factor required for IVDU to cause IE is myocardial tissue damage that
has produced a vegetation. Research shows that chronic IVDU can cause non-bacterial vegetations on heart
valves due to the repetitive damage from injected particular matter (UpToDate, 2018)

•

• Neurological complications – According to Habib et al. (2015), Transient ischemic attack, intracerebral
or subarachnoidal haemorrhage, brain abscess, meningitis, infectious (mycotic) aneurysm and toxic
encephalopathy are also seen, and firm evidence supports that additional clinically silent cerebral
embolisms occur in 35–60% of IE patients” (p. 28).

• If a patient has a confirmed IE (especially left sided), monitor the patient for complications
such as emobolization of the vegetation to other organs (decreased urine output, confusion,
abdominal/back pain, shortness of breath, increasing chest pain).
•

Conclusion

IE is a significant diagnosis because of its ability to affect almost every vital body system.

•Nurses must also know the correct procedure for drawing blood cultures in order to avoid
contamination of the specimen.
• The nurse must also be able to properly educate the patient on IVDU cessation and the
instance of reoccurrence of IE in IVDU.
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